Header cover image

U.K. (FTSE) Biotech Industry Analysis

UpdatedMay 31, 2025
DataAggregated Company Financials
Companies21
  • 7D1.9%
  • 3M0.4%
  • 1Y-12.9%
  • YTD-2.3%

Faron Pharmaceuticals Oy is up 12%, leading the way for the Biotech industry, which has gained 1.9%. In contrast, the industry has lost 13% in the last 12 months. Looking forward, earnings are forecast to grow by 32% annually.

Industry Valuation and Performance

Has the U.K. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 31 May 2025UK£2.5bUK£878.9m-UK£89,048,731.0013.9x-27.6x2.8x
Mon, 28 Apr 2025UK£2.1bUK£876.5m-UK£171,010,503.1117.2x-12.3x2.4x
Wed, 26 Mar 2025UK£2.4bUK£844.1m-UK£277,247,408.9117.1x-8.5x2.8x
Fri, 21 Feb 2025UK£2.6bUK£841.6m-UK£293,966,421.1082.6x-8.9x3.1x
Sun, 19 Jan 2025UK£2.7bUK£842.7m-UK£297,345,767.1285.2x-9.2x3.2x
Tue, 17 Dec 2024UK£2.7bUK£841.5m-UK£293,734,272.2579x-9.1x3.2x
Thu, 14 Nov 2024UK£2.8bUK£840.8m-UK£293,945,911.9986.4x-9.4x3.3x
Sat, 12 Oct 2024UK£2.9bUK£840.2m-UK£295,599,113.8297.1x-10x3.5x
Mon, 09 Sep 2024UK£2.7bUK£830.5m-UK£314,446,085.3282.9x-8.7x3.3x
Wed, 07 Aug 2024UK£2.6bUK£838.4m-UK£258,170,344.8830.3x-10x3.1x
Fri, 05 Jul 2024UK£2.6bUK£835.6m-UK£260,791,630.7730.3x-10.1x3.1x
Sun, 02 Jun 2024UK£3.0bUK£836.3m-UK£287,266,028.4030.6x-10.3x3.6x
Tue, 30 Apr 2024UK£3.2bUK£895.7m-UK£215,376,495.2431.2x-14.7x3.5x
Thu, 28 Mar 2024UK£3.1bUK£903.1m-UK£202,126,857.0428.4x-15.3x3.4x
Sat, 24 Feb 2024UK£3.3bUK£896.7m-UK£197,698,774.8532.6x-16.7x3.7x
Mon, 22 Jan 2024UK£6.4bUK£1.3b-UK£245,297,001.0037.3x-25.9x5x
Wed, 20 Dec 2023UK£6.2bUK£1.3b-UK£245,101,181.0037.5x-25.4x4.9x
Fri, 17 Nov 2023UK£6.5bUK£1.3b-UK£242,542,229.0038.6x-26.6x5.1x
Sun, 15 Oct 2023UK£6.6bUK£1.3b-UK£251,303,385.0038.4x-26.1x5.1x
Tue, 12 Sep 2023UK£6.6bUK£1.3b-UK£206,702,008.0023.6x-31.7x5.1x
Thu, 10 Aug 2023UK£6.8bUK£1.3b-UK£207,967,768.0023.6x-32.5x5.4x
Sat, 08 Jul 2023UK£6.7bUK£1.3b-UK£208,510,181.0023.9x-32.2x5.3x
Mon, 05 Jun 2023UK£7.0bUK£1.3b-UK£204,603,564.0022.6x-34.3x5.6x
Wed, 03 May 2023UK£7.1bUK£1.3b-UK£206,395,552.0023.7x-34.2x5.6x
Fri, 31 Mar 2023UK£7.2bUK£1.2b-UK£154,920,420.0024x-46.2x5.8x
Sun, 26 Feb 2023UK£7.4bUK£1.2b-UK£156,977,013.0026.1x-47.4x6x
Tue, 24 Jan 2023UK£7.6bUK£1.2b-UK£140,066,429.0027.6x-54.6x6.6x
Thu, 22 Dec 2022UK£7.5bUK£1.2b-UK£138,236,364.0026.7x-54x6.4x
Sat, 19 Nov 2022UK£7.8bUK£1.2b-UK£139,984,413.0025.1x-55.6x6.7x
Mon, 17 Oct 2022UK£7.0bUK£1.2b-UK£150,681,291.0026.2x-46.7x6.1x
Wed, 14 Sep 2022UK£7.6bUK£1.1b-UK£144,420,164.0035.4x-52.4x6.6x
Fri, 12 Aug 2022UK£7.5bUK£1.1b-UK£200,200,136.0037.6x-37.3x6.7x
Sun, 10 Jul 2022UK£7.1bUK£1.1b-UK£175,037,886.0036.3x-40.4x6.3x
Tue, 07 Jun 2022UK£7.2bUK£1.1b-UK£156,741,499.0038.4x-46x6.5x
Price to Earnings Ratio

-46x


Total Market Cap: UK£7.2bTotal Earnings: -UK£156,741,499.00Total Revenue: UK£1.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Biotech Industry Price to Earnings3Y Average -30.8x202320242025
Current Industry PE
  • Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.1x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 7.6% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.58%
Healthcare2.88%
Biotech1.91%
Biotech1.91%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FARN Faron Pharmaceuticals OyUK£2.6311.7%
+UK£47.4m
41.9%PE-15.6x
AVCT Avacta GroupUK£0.3838.2%
+UK£40.9m
-5.9%PS6.6x
OXB Oxford BiomedicaUK£3.251.6%
+UK£5.3m
-1.8%PS2.7x
PRTC PureTech HealthUK£1.360.9%
+UK£2.9m
-41.8%PE8.2x
PBX ProBiotix HealthUK£0.08322.2%
+UK£2.4m
65.0%PS6.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CIZ

UK£0.024

Cizzle Biotechnology Holdings

7D

27.0%

1Y

40.3%

PBX

UK£0.083

ProBiotix Health

7D

22.2%

1Y

65.0%

4BB

UK£11.10

4basebio

7D

-1.3%

1Y

-20.7%

FARN

UK£2.63

Faron Pharmaceuticals Oy

7D

11.7%

1Y

41.9%

OXB

UK£3.25

Oxford Biomedica

7D

1.6%

1Y

-1.8%

GENF

UK£0.0085

Genflow Biosciences

7D

-5.6%

1Y

-72.1%

OPTI

UK£0.14

OptiBiotix Health

7D

-1.7%

1Y

-20.5%

PRTC

UK£1.36

PureTech Health

7D

0.9%

1Y

-41.8%

0A4Y

US$0.078

AIM ImmunoTech

7D

-11.6%

1Y

-79.9%

HEMO

UK£1.76

Hemogenyx Pharmaceuticals

7D

-0.3%

1Y

-70.1%

AVCT

UK£0.38

Avacta Group

7D

38.2%

1Y

-5.9%

0KF3

US$0.095

Palatin Technologies

7D

-7.2%

1Y

-94.7%

SCLP

UK£0.10

Scancell Holdings

7D

1.0%

1Y

-1.0%

BVXP

UK£29.25

Bioventix

7D

0.9%

1Y

-32.0%